Works matching DE "THERAPEUTIC use of iron chelates"

Results: 55

THE USE OF ANABOLIC THERAPY IN PATIENTS WITH BETA-THALASSEMIA MAJOR-INDUCED OSTEOPOROSIS - REVIEW OF THE LITERATURE.

Published in:

Farmacia, 2017, v. 65, n. 2, p. 167

By:

CIMA, LUMINIȚA-NICOLETA;
FICA, SIMONA

Publication type:

Article

Clinical Experience With Deferiprone Treatment for Friedreich Ataxia.

Published in:

Journal of Child Neurology, 2016, v. 31, n. 8, p. 1036, doi. 10.1177/0883073816636087

By:

Elincx-Benizri, Sandra;
Glik, Amir;
Merkel, Drorit;
Arad, Michael;
Freimark, Dov;
Kozlova, Evgenia;
Cabantchik, Ioav;
Hassin-Baer, Sharon

Publication type:

Article

Physiological study for some blood parameters in patients with major β-Thalassemia in Sulaymaniyah, Kurdistan, Iraq.

Published in:

Tikrit Medical Journal, 2016, v. 21, n. 1, p. 187

By:

Rija, Firas F.

Publication type:

Article

Combined Chelation Therapy with Daily Oral Deferiprone and Twice-Weekly Subcutaneous Infusion of Desferrioxamine in Children with β-Thalassemia: 3-Year Experience.

Published in:

Acta Haematologica, 2015, v. 133, n. 2, p. 226, doi. 10.1159/000363210

By:

Songdej, Duantida;
Sirachainan, Nongnuch;
Wongwerawattanakoon, Pakawan;
Sasanakul, Werasak;
Kadegasem, Praguywan;
Sungkarat, Witaya;
Chuansumrit, ampaiwan

Publication type:

Article

Improvement in Hematopoiesis after Iron Chelation Therapy with Deferasirox in Patients with Aplastic Anemia.

Published in:

Acta Haematologica, 2013, v. 129, n. 2, p. 72, doi. 10.1159/000342772

By:

Lee, Sung-Eun;
Yahng, Seung-Ah;
Cho, Byung-Sik;
Eom, Ki-Sung;
Kim, Yoo-Jin;
Lee, Seok;
Min, Chang-Ki;
Kim, Hee-Je;
Cho, Seok-Goo;
Kim, Dong-Wook;
Min, Woo-Sung;
Park, Chong-Won;
Lee, Jong Wook

Publication type:

Article

Deferasirox Treatment Interruption in a Transfusion-Requiring Myelodysplastic Patient Led to Loss of Erythroid Response.

Published in:

Acta Haematologica, 2010, v. 124, n. 1, p. 46, doi. 10.1159/000314961

By:

Breccia, Massimo;
Loglisci, Giuseppina;
Salaroli, Adriano;
Cannella, Laura;
Santopietro, Michelina;
Alimena, Giuliana

Publication type:

Article

ACMT Recommends Against Use of Post-Chelator Challenge Urinary Metal Testing.

Published in:: Journal of Medical Toxicology, 2017, v. 13, n. 4, p. 352, doi. 10.1007/s13181-017-0624-6
Publication type:: Article

Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.

Published in:

2016

By:

Hirofumi Harima;
Seiji Kaino;
Taro Takami;
Shuhei Shinoda;
Toshihiko Matsumoto;
Koichi Fujisawa;
Naoki Yamamoto;
Takahiro Yamasaki;
Isao Sakaida;
Harima, Hirofumi;
Kaino, Seiji;
Takami, Taro;
Shinoda, Shuhei;
Matsumoto, Toshihiko;
Fujisawa, Koichi;
Yamamoto, Naoki;
Yamasaki, Takahiro;
Sakaida, Isao

Publication type:

journal article

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.

Published in:

Journal of Blood Medicine, 2015, v. 6, p. 197, doi. 10.2147/JBM.S72463

By:

Saliba, Antoine N.;
Harb, Afif R.;
Taher, Ali T.

Publication type:

Article

Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis.

Published in:

Expert Review of Clinical Pharmacology, 2018, v. 11, n. 6, p. 641, doi. 10.1080/17512433.2018.1473760

By:

Sridharan, Kannan;
Sivaramakrishnan, Gowri

Publication type:

Article

Iron: the hard player in diabetes pathophysiology.

Published in:

Acta Physiologica, 2014, v. 210, n. 4, p. 717, doi. 10.1111/apha.12256

By:

Hansen, J. B.;
Moen, I. W.;
Mandrup‐Poulsen, T.

Publication type:

Article

Incidence of testicular microlithiasis in patients with β-thalassemia major.

Published in:

2015

By:

Rahimi, Rahil;
Foroughi, Amin;
Haghpanah, Sezaneh;
Bahmanyar, Maryam;
Jelodari, Shohreh;
De Sanctis, Vincenzo;
Karimi, Mehran;
Foroughi, Amin Abolhasani

Publication type:

journal article

Deferiprone as an oral iron chelator in sickle cell disease.

Published in:

2005

By:

Voskaridou, Ersi;
Douskou, Maroussa;
Terpos, Evangelos;
Stamoulakatou, Alexandra;
Meletis, John;
Ourailidis, Akis;
Papassotiriou, Ioannis;
Loukopoulos, Dimitris

Publication type:

journal article

Reversal of cardiac complications in thalassemia major by long-term intermittent daily intensive iron chelation.

Published in:

European Journal of Haematology, 2003, v. 70, n. 6, p. 398, doi. 10.1034/j.1600-0609.2003.00075.x

By:

Miskin, H.;
Yaniv, I.;
Berant, M.;
Hershko, C.;
Tamary, H.

Publication type:

Article

Combined and alternative iron chelator drugs in treatment of thalassemia major.

Published in:

Pakistan Journal of Medical Sciences, 2011, v. 27, n. 3, p. 630

By:

Keikhaei, Bijan

Publication type:

Article

Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.

Published in:

2017

By:

Horodniceanu, Erica G.;
Bal, Vasudha;
Dhatt, Harman;
Carter, John A.;
Vicky Huang;
Lasch, Kathryn;
Huang, Vicky

Publication type:

journal article

Physiological study for some blood parameters in patients with major β-Thalassemia in Sulaymaniyah, Kurdistan, Iraq.

Published in:

Medical Journal of Tikrit, 2016, v. 21, n. 1, p. 187

By:

Rija, Firas F.

Publication type:

Article

Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment.

Published in:

2017

By:

Poli, L.;
Alberici, A.;
Buzzi, P.;
Marchina, E.;
Lanari, A.;
Arosio, C.;
Ciccone, A.;
Semeraro, F.;
Gasparotti, R.;
Padovani, A.;
Borroni, Barbara

Publication type:

journal article

Deferasirox associated with liver failure and death in a sickle cell anemia patient homozygous for the −1774delG polymorphism in the Abcc2 gene.

Published in:

Clinical Case Reports, 2017, v. 5, n. 8, p. 1218, doi. 10.1002/ccr3.1040

By:

Braga, Caroline C. B.;
Benites, Bruno Deltreggia;
Albuquerque, Dulcineia M.;
Alvarez, Marisa C.;
Seva‐Pereira, Tiago;
Duarte, Bruno K. L.;
Costa, Fernando F.;
Gilli, Simone C. O.;
Saad, Sara T. O.

Publication type:

Article

Durable Red Blood Cell Transfusion Independence in a Patient with an MDS/MPN Overlap Syndrome Following Discontinuation of Iron Chelation Therapy.

Published in:

Case Reports in Hematology, 2015, v. 2015, p. 1, doi. 10.1155/2015/253294

By:

Kochhar, Harpreet;
Leger, Chantal S.;
Leitch, Heather A.

Publication type:

Article

Iron Chelators Inhibit the Growth and Induce the Apoptosis of Kaposi's Sarcoma Cells and of their Putative Endothelial Precursors.

Published in:

Journal of Investigative Dermatology, 2000, v. 115, n. 5, p. 893, doi. 10.1046/j.1523-1747.2000.00119.x

By:

Simonart, Thierry;
Degraef, Chantal;
Andrei, Graciela;
Mosselmans, Roger;
Hermans, Philippe;
Van Vooren, Jean-Paul;
Noel, Jean-Christophe;
Boelaert, Johan R.;
Snoeck, Robert;
Heenen, Michel

Publication type:

Article

Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia.

Published in:

British Journal of Haematology, 2010, v. 151, n. 5, p. 504, doi. 10.1111/j.1365-2141.2010.08346.x

By:

Ladis, Vassilis;
Berdousi, Helen;
Gotsis, Efstathios;
Kattamis, Antonis

Publication type:

Article

Wrist Deformity in Children and Adolescents with β-thalassemia on Oral Iron Chelation Therapy.

Published in:

Indian Pediatrics, 2019, v. 56, n. 1, p. 41, doi. 10.1007/s13312-019-1465-y

By:

Merchant, Rashid H.;
Kulkarni, Ameya;
Doctor, Pezad N.;
Choudhari, Amitkumar;
Patkar, Deepak P.

Publication type:

Article

Treatment options for thalassemia patients with osteoporosis.

Published in:

Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 237, doi. 10.1111/j.1749-6632.2010.05542.x

By:

Terpos, Evangelos;
Voskaridou, Ersi

Publication type:

Article

Humanized mouse models of Cooley's anemia: correct fetal-to-adult hemoglobin switching, disease onset, and disease pathology.

Published in:

Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 45, doi. 10.1111/j.1749-6632.2010.05547.x

By:

Huo, Yongliang;
McConnell, Sean C.;
Liu, Shanrun;
Zhang, Tingting;
Yang, Rui;
Ren, Jinxiang;
Ryan, Thomas M.

Publication type:

Article

Cardiovascular MRI in thalassemia major.

Published in:

Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 173, doi. 10.1111/j.1749-6632.2010.05571.x

By:

Wood, John C;
Noetzli, Leila

Publication type:

Article

Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron.

Published in:

Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 94, doi. 10.1111/j.1749-6632.2010.05573.x

By:

Hider, R.C.;
Silva, A.M.N.;
Podinovskaia, M.;
Ma, Yongmin

Publication type:

Article

The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia.

Published in:

Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 10, doi. 10.1111/j.1749-6632.2010.05577.x

By:

Fibach, Eitan;
Rachmilewitz, Eliezer A.

Publication type:

Article

Deferasirox—current knowledge and future challenges.

Published in:

Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 87, doi. 10.1111/j.1749-6632.2010.05582.x

By:

Porter, John B.

Publication type:

Article

Combined iron chelation therapy.

Published in:

Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 79, doi. 10.1111/j.1749-6632.2010.05591.x

By:

Galanello, Renzo;
Agus, Annalisa;
Campus, Simona;
Danjou, Fabrice;
Giardina, Patricia J.;
Grady, Robert W.

Publication type:

Article

Randomized, Blinded, Placebo- and Positive-Controlled Crossover Study to Determine the Effect of Deferiprone on the QTc Interval in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 22, doi. 10.1002/cpdd.352

By:

Fradette, Caroline;
Rozova, Anna;
Stilman, Anne;
Tsang, Yu Chung;
Allison, Mark J.;
Tricta, Fernando

Publication type:

Article

Ciprofloxacin: a novel therapeutic agent for iron overload?

Published in:

Turkish Journal of Hematology, 2009, v. 26, n. 3, p. 114

By:

Elmi, Mitra;
Rahimi-Moghaddam, Parvaneh;
Abdi, Khosrou;
Shafiee-Ardestani, Mehdi;
Mahmoudian, Massoud

Publication type:

Article

Interactions of the pyridine-2-carboxaldehyde isonicotinoyl hydrazone class of chelators with iron and DNA: implications for toxicity in the treatment of iron overload disease.

Published in:

Journal of Biological Inorganic Chemistry (JBIC), 2003, v. 8, n. 4, p. 427, doi. 10.1007/s00775-002-0434-3

By:

Timothy B. Chaston;
Des R. Richardson

Publication type:

Article

1475 – Chelation therapy impact and its correlation with the psychological parameters in patients with thalassaemia.

Published in:

2013

By:

Lyrakos, G.N.;
Vini, D.;
Spinaris, V.;
Aslani, H.;
Drossou- Servou, M.

Publication type:

Abstract

A Review on Iron Chelators in Treatment of Iron Overload Syndromes.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2016, v. 10, n. 4, p. 239

By:

Mobarra, Naser;
Shanaki, Mehrnoosh;
Ehteram, Hassan;
Nasiri, Hajar;
Sahmani, Mehdi;
Saeidi, Mohsen;
Goudarzi, Mehdi;
Pourkarim, Hoda;
Azad, Mehdi

Publication type:

Article

Iron Chelation Therapy: Past, Present, and Future Prospects.

Published in:

European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 3, p. 1

By:

Hoffbrand, Victor

Publication type:

Article

In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.

Published in:

PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139929

By:

Potůčková, Eliška;
Roh, Jaroslav;
Macháček, Miloslav;
Sahni, Sumit;
Stariat, Ján;
Šesták, Vít;
Jansová, Hana;
Hašková, Pavlína;
Jirkovská, Anna;
Vávrová, Kateřina;
Kovaříková, Petra;
Kalinowski, Danuta S.;
Richardson, Des R.;
Šimůnek, Tomáš

Publication type:

Article

Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity.

Published in:

PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085115

By:

Sripetchwandee, Jirapas;
Pipatpiboon, Noppamas;
Chattipakorn, Nipon;
Chattipakorn, Siriporn

Publication type:

Article

Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.

Published in:

Journal of Neural Transmission, 2015, v. 122, n. 4, p. 559, doi. 10.1007/s00702-014-1307-y

By:

Sofic, E.;
Salkovic-Petrisic, M.;
Tahirovic, I.;
Sapcanin, A.;
Mandel, S.;
Youdim, M.;
Riederer, P.

Publication type:

Article

Editorial.

Published in:

Indian Pediatrics, 2016, v. 53, n. 3, p. 199, doi. 10.1007/s13312-016-0819-y

By:

Yadav, Satya;
Chadha, Rajiv;
Khan, Niyaz

Publication type:

Article

Comparative efficacy and safety of oral iron chelators and their novel combination in children with thalassemia.

Published in:

Indian Pediatrics, 2016, v. 53, n. 3, p. 207, doi. 10.1007/s13312-016-0821-4

By:

Gomber, Sunil;
Jain, Prachi;
Sharma, Satender;
Narang, Manish

Publication type:

Article

The ferric iron chelator 2,2′-dipyridyl attenuates basilar artery vasospasm and improves neurological function after subarachnoid hemorrhage in rabbits.

Published in:

Neurological Sciences, 2014, v. 35, n. 9, p. 1413, doi. 10.1007/s10072-014-1730-8

By:

Yu, Yaoyu;
Lin, Zhichun;
Yin, Yiheng;
Zhao, Jianwu

Publication type:

Article

MagA increases MRI sensitivity and attenuates peroxidation-based damage to the bone-marrow haematopoietic microenvironment caused by iron overload.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, p. S18, doi. 10.1080/21691401.2018.1489260

By:

Shen, Yingying;
Zheng, Cunjing;
Tan, Yunpu;
Jiang, Xinhua;
Li, Li

Publication type:

Article

Safety profile of a liquid formulation of deferiprone in young children with transfusion-induced iron overload: a 1-year experience.

Published in:

Paediatrics & International Child Health, 2016, v. 36, n. 3, p. 209, doi. 10.1179/2046905515Y.0000000040

By:

Chuansumrit, Ampaiwan;
Songdej, Duantida;
Sirachainan, Nongnuch;
Wongwerawattanakoon, Pakawan;
Kadegasem, Praguywan;
Sasanakul, Werasak

Publication type:

Article

Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.

Published in:

European Journal of Neurology, 2017, v. 24, n. 2, p. 357, doi. 10.1111/ene.13208

By:

Martin ‐ Bastida, A.;
Lao ‐ Kaim, N. P.;
Loane, C.;
Politis, M.;
Roussakis, A. A.;
Valle ‐ Guzman, N.;
Kefalopoulou, Z.;
Paul ‐ Visse, G.;
Widner, H.;
Xing, Y.;
Schwarz, S. T.;
Auer, D. P.;
Foltynie, T.;
Barker, R. A.;
Piccini, P.

Publication type:

Article

Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major.

Published in:

Frontiers in Pharmacology, 2014, v. 5, p. 1, doi. 10.3389/fphar.2014.00217

By:

Baksi, A. John;
Pennell, Dudley J.

Publication type:

Article

Role of iron metabolism genetic determinants in response to chelation therapy in a cohort of β-thalassemia and sickle cell syndromes Italian patients.

Published in:

Thalassemia Reports, 2014, v. 4, n. 2, p. 28, doi. 10.4081/thal.2014.2729

By:

Renda, Maria Concetta;
Renda, Disma;
Piazza, Angela;
Calvaruso, Giuseppina;
Fecarotta, Emanuela;
Giangreco, Antonino;
Maggio, Aurelio

Publication type:

Article

Recent developments centered on oraly active iron chelators.

Published in:

Thalassemia Reports, 2014, v. 4, n. 2, p. 19, doi. 10.4081/thal.2014.2261

By:

Hider, Robert

Publication type:

Article

Iron chelating agents for iron overload diseases.

Published in:

Thalassemia Reports, 2014, v. 4, n. 2, p. 13, doi. 10.4081/thal.2014.2046

By:

Crisponi, Guido;
Nurchi, Valeria Marina;
Zoroddu, Maria Antonietta

Publication type:

Article

Thalassemia: a dreadful disease turned to a chronic condition.

Published in:

Thalassemia Reports, 2013, v. 3, n. 1s, p. 3, doi. 10.4081/thal.2013.s1.e2

By:

Loukopoulos, Dimitris

Publication type:

Article